๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea ยท Delayed Price ยท Currency is KRW
462,000
+40,000 (9.48%)
Nov 20, 2026, 1:05 PM KST

Hanmi Pharm. Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,562,6311,547,5311,495,5021,490,8871,331,5471,203,186
Revenue Growth
6.58%3.48%0.31%11.97%10.67%11.83%
Gross Profit
880,407884,407817,037829,249718,553632,752
Operating Income
206,570223,870212,511224,885153,896125,416
Net Income
138,154169,554121,315146,23182,79267,025
Earnings Per Share
10887.4413362.009566.8311522.126517.335269.87
EPS Growth
18.52%39.67%-16.97%76.79%23.67%461.07%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Reconciliation of Inter-Sector Transactions
-92,766-113,143-114,815-101,689-89,719
Overseas Pharmaceuticals
402,395385,630397,690350,640288,729
Active Pharmaceutical Ingredients
91,280108,892111,067100,54787,158
Medicine
1,146,6221,114,1231,096,946982,049917,018
Total
1,547,5311,495,5021,490,8871,331,5471,203,186

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
-201,322193,195255,183236,736211,734
Total Debt
-434,211496,687572,867678,323756,267
Net Cash (Debt)
--232,889-303,492-317,685-441,586-544,532
Net Cash Growth
------
Net Cash Per Share
--18353.48-23933.19-25031.60-34761.50-42813.87

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-173,072193,487216,538162,269201,923
Capital Expenditures
--43,025-39,261-27,352-30,378-19,949
Free Cash Flow
-130,048154,226189,186131,890181,974
Free Cash Flow Growth
--15.68%-18.48%43.44%-27.52%65.85%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-57.15%54.63%55.62%53.96%52.59%
Operating Margin
13.22%14.47%14.21%15.08%11.56%10.42%
Pretax Margin
11.10%13.79%11.45%13.01%9.09%8.62%
Profit Margin
8.84%10.96%8.11%9.81%6.22%5.57%
FCF Margin
-8.40%10.31%12.69%9.90%15.12%

Dividends

Fiscal Year
CurrentFY 2025
Period EndingNov '26 Dec '25
Dividend Per Share
2000.0002000.000
Dividend Per Share Growth
0%-
Dividend Yield
0.43%0.44%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
42.4333.8029.3230.5944.8350.34
Forward PE
24.9333.6419.5430.5738.0144.63
P/FCF Ratio
27.0644.0723.0623.6528.1418.54
PS Ratio
3.753.702.383.002.792.80